Corrigendum to "Risk factors for interstitial lung disease in patients with non-small cell lung cancer with epidermal growth factor receptor-tyrosine kinase inhibitors: A systematic review and meta-analysis" [Respir Invest, Volume 62, Issue 3, May 2024, Pages 481-487]
- PMID: 40044544
- DOI: 10.1016/j.resinv.2025.02.006
Corrigendum to "Risk factors for interstitial lung disease in patients with non-small cell lung cancer with epidermal growth factor receptor-tyrosine kinase inhibitors: A systematic review and meta-analysis" [Respir Invest, Volume 62, Issue 3, May 2024, Pages 481-487]
Erratum for
-
Risk factors for interstitial lung disease in patients with non-small cell lung cancer with epidermal growth factor receptor-tyrosine kinase inhibitors: A systematic review and meta-analysis.Respir Investig. 2024 May;62(3):481-487. doi: 10.1016/j.resinv.2024.03.007. Epub 2024 Apr 3. Respir Investig. 2024. PMID: 38569441
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
